Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: Chemistry, biological evaluations, and therapeutic prospectsBrigitte Bauvois, Daniel Dauzonne|Medicinal Research Reviews|2005Cited by 265
ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemiaMariana Tannoury, Santos A. Susín, Léa Dehgane et al.|Leukemia|2023Cited by 30
Targeting CD13 (aminopeptidase-N) in turn downregulates ADAM17 by internalization in acute myeloid leukaemia cellsSandrine Bouchet, Brigitte Bauvois|Oncotarget|2014Cited by 15